Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-Up Compared With Natural Infection.
Camilo J AcostaClemente DiazFrancesco NordioHtay-Htay HanKelley J MossKelly BohningPradeep KumarMengya LiuHetal PatelFilippo PacciariniVincent MwangiElke WalterTim D PowellHana M El SahlyWhitney R BaldwinJoseph SantangeloLarry J AndersonGary DubinPublished in: The Journal of infectious diseases (2022)
ClinicalTrials.gov NCT03343626.
Keyphrases